Data flow in the Luxembourg COVID-19 joint initiative: a blueprint for data-driven translational medicine

  1. Irina Balaur
  2. Piyapong Khumrin
  3. Soumyabrata Ghosh
  4. Dmitry Bulaev
  5. Priyanka Mendon
  6. Kavita Rege
  7. Milena Despotovic
  8. Sarah Peter
  9. Rajesh Rawal
  10. Jochen Ohnmacht
  11. Joëlle V. Fritz
  12. Marc Paul O’Sullivan
  13. Carlo Haller
  14. Vanessa Di Bartolomeo
  15. Christophe Shinn
  16. Rejko Krüger
  17. Guy Fagherazzi
  18. Paul Wilmes
  19. Michel Vaillant
  20. Venkata Satagopam
Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

CoVaLux is a unique national scientific consortium studying COVID-19, vaccination, and long-term health outcomes in Luxembourg. The program combines data from multiple research initiatives in a secure environment, establishing an effective framework for data management and analysis. Here, we delineate the development of the CoVaLux data flow, addressing critical requirements and showcasing how CoVaLux can serve as a model for similar medical research projects worldwide, particularly in pandemic preparation.

Article activity feed

  1. Version published to 10.21203/rs.3.rs-7114519/v1 on Research Square